EDMA welcomes new Executive Committee

Press release

On 17 October, the General Assembly members voted to appoint Philippe Jacon, President, High Burden and Developing Countries, Cepheid and Christian Parry, Director, Production, Stago representing the French National Association for IVDs (SIDIV) as Vice Presidents of EDMA. Paul Arnaoutis, Chairman of Paul Arnaoutis S.A.representing, the Greek National Association for IVDs (SEIV); Vicky Voulgaraki, Director Government Relations and Public Affairs, Europe, Thermo Fisher Scientific; Michael Heuer, President, EMEA, Roche Diagnostics; Nadav Tomer, Regional Vice President LifeScan EMEA, Johnson & Johnson; John Coulter, Vice President, Diagnostics, Commercial Operations, EMEA, Abbott Diagnostics; Tadeusz Tuora, President, Orphee Technics Sp. Zo.o., representing the Polish National Association for IVDs and Lorenzo Fracassi, Managing Director, Dasit Group, representing the Italian National Association (Assobiomedica) were also elected to EDMA Executive Committee.

The EDMA Executive Committee would like to thank Vivian Wang, President, EMEA, LifeScan and Kathy Turner, former Divisional Vice President, Abbott Diagnostics for their vital contributions to the Committee.

“We’re happy to have Philippe and Christian as Vice Presidents and warmly welcome the newly elected members to the Executive Committee,” said EDMA Executive Committee President Dr Jürgen Schulze, CEO and President EMEA, Sysmex. “We have interesting and challenging times ahead of us and EDMA’s performance depends on the support and contributions of all members.”


About EDMA

European Diagnostic Manufacturers Association (EDMA) is an international, non-profit organisation representing the interests of the medical in vitro diagnostics (IVD) industry in Europe. Its mission is to promote the value of IVDs in delivering sustainable and effective public health systems, and provide technical, regulatory and market research information to its members. The European IVD industry is a market worth around €11 billion. Driven by research and development, 95% of the industry is comprised of small and medium size enterprises and approximately 1 billion euros per year is reinvested in R&D. EDMA is a member of MedTech Europe, an alliance of European medical technology industry associations. For more information, visit www.edma-ivd.eu